Gentiva Reports First Quarter 20... (a.com/events.cfm to hear the web cast. ...)

Gentiva Reports First Quarter 2009 Results

Date:4/30/2009

a.com/events.cfm to hear the web cast. A replay of the call will be available on April 30, beginning at approximately 1 p.m. ET, and will remain available continuously through May 7. To listen to a replay of the call from the United States, Canada or international locations, dial (800) 642-1687 or (706) 645-9291 and enter the following PIN at the prompt: 94103101. Visit http://investors.gentiva.com/events.cfm to access the web cast archive. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call is expected to be available on the site within 48 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is a leading provider of comprehensive home health services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-E

(tables and notes follow)

(in 000's, except per share data) 1st Quarter
-----------
2009 2008
---- ----
'/>"/>
SOURCE Gentiva Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved
0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related medicine news :

Post Your Comments:

(Date:12/15/2009)... cardiovascular event, suicide goes up within a week ... 15 (HealthDay News) -- Emotional stress can put ... for cardiovascular events and suicide, a new study ... Swedish men diagnosed with prostate cancer between 1961 ... experienced a cardiovascular event within a year of ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, In-Vitro ... U.S. and its International Trade [Q4 ... ,, The newly published In-Vitro ... the latest market research on the ...

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... STAMFORD, Conn., Dec. 15 Aon ... of Aon Corporation (NYSE: AON ... the firm as senior vice president with ... of the national Pharmacy Practice. ,, ... her new role, Zeitel will work under ...

(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...

[0] Stress From Prostate Cancer Diagnosis May Be Fatal [0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business

... increases 88% and net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, ... or "Our") (NYSE:,DR) today announced its financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross ...

... Rights to Bystolic(TM) (Nebivolol) for $370 Million in Cash ... To Consider a Sale of Dey Specialty Business, PITTSBURGH, Feb. ... results for the three and nine months ended,December 31, 2007, provided ... announced a number of strategic and operational,initiatives., Financial Highlights, ...

... Offers Unique Formulation of Important Cancer Medication -, ... Inc.,(NYSE: HSP ), the world leader in ... hydrochloride injection in the United,States. The medication is ... U.S. sales of more than $545 million. Irinotecan ...

... board of trustees approved a proposal today to create ... pharmacy program will serve a total of 300 students ... of 2010., The proposal, which was presented to ... two years of research and study conducted by,members of ...

... Dr. Shawn Hook of Arbor Ridge,Clinic in Madison, Wisconsin ... Great Vectra 3D(TM)" $125,000 Giveaway. Dr. Hook is the,first ... in,medical equipment for his veterinary clinic. There will be ... March, and a final grand prize,winner who will win ...

... WASHINGTON, Feb. 27 Children with special,needs will ... environment levels in,District households. Health Services for Children ... Safe D.C., has begun offering free,in-home lead testing ... needs. The collaboration will initially focus on children ...

Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter Hospira Launches Generic Irinotecan Injection PC Trustees Vote to Start New Pharmacy School in S.C.Summit VetPharm Announces First Winner in its 'Great Vectra 3D(TM)' $125,000 Giveaway Lead Safe D.C. and HSCSN Bring Lead Poisoning Prevention to The District's Children With Special Needs

(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...

(Date:12/15/2009)... Dec. 15 At today,s regular meeting of ... LZ ), the board declared a regular ... 10, 2010 to holders of record at the close ... The Lubrizol Corporation ,, The Lubrizol Corporation (NYSE: ... company that produces and supplies technologies that improve the ...

(Date:12/15/2009)... 15 Today, Hill-Rom Holdings, Inc. (NYSE: ... progress on significant strategic and financial initiatives at ... The Conference is hosted by Peter H. Soderberg, ... presentations on the following topics: ,, Status ... and development and financial updates Smart technologies ...

Breaking Medicine Technology:Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7 Lubrizol Declares Dividend 2 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7 Getting College Students To Wash Hands Halt Disease Requires Giving Them Proper Tools and Spreading The Word In Ways That Get Attention Say K State 56268 1 Getting College Students To Wash Hands Halt Disease Requires Giving Them Proper Tools and Spreading The Word In Ways That Get Attention Say K State 56268 2 Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 1 Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 2 Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 3 Surgical scrub solution 3A Its good for patients too 56263 1 Surgical scrub solution 3A Its good for patients too 56263 2 Surgical scrub solution 3A Its good for patients too 56263 3 Surgical scrub solution 3A Its good for patients too 56263 4

[0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Lubrizol Declares Dividend [0] Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies

... Class, of Stent with Polyzene(R)-F Surface ... for Long-Term,Dual Antiplatelet Therapy, WASHINGTON, ... today,s,"Innovative Devices and Futuristic Therapies" session ... (TCT) scientific,symposium, sponsored by the Cardiovascular ...

... in Combination with Chemotherapy, FREMONT, Calif. ... pharmaceutical company discovering and developing novel,RNA interference ... Research published results on efficacy of siRNA ... lung cancer (NSCLC) in,the edition dated October ...

Other Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 2 12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 3 12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4

12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy

... allows you to tailor to your specialty. ... Synchronous Processing Technology. The technology delivers a ... all operational modes. Advanced Digital Signal architecture ... voltage over 450,000 times per second and ...

... based adhesive supplied as a phase ... a liquid substrate and crosslinker useful ... When combined the materials ... prepared wound and tenaciously adhere to ...

The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...

... DERMABOND* Topical Skin Adhesive gives you new ... is intended for topical application only to ... wounds from surgical incisions, including punctures from ... trauma-induced lacerations. DERMABOND adhesive may be used ...

Medicine Products:

The System 5000 PoliPhase®DuraSeal Dural Sealant DERMABOND

Gentiva Reports First Quarter 20...(a.com/events.cfm to hear the web cast. ...),Health